Update shared on 02 Dec 2025
Fair value Increased 0.73%Straumann Holding’s analyst price target has been lifted modestly to CHF 112.43 from CHF 111.61, as analysts reflect improved U.S. operational momentum and a recent shift in sentiment following the company’s quarterly report.
Analyst Commentary
Recent street research reflects a dynamic range of viewpoints on Straumann Holding, as analysts weigh evolving sentiment and operational signals primarily from the U.S. market. Perspectives are divided between optimism surrounding momentum and valuation, as well as caution regarding growth headwinds and market recovery.
Bullish Takeaways
- Bullish analysts highlight a clear improvement in Straumann's operational momentum in the U.S., which is seen as a foundation for renewed growth.
- Some have upgraded their outlook and price targets in response to a positive shift in investor sentiment following the company’s third-quarter report.
- There is growing consensus that negative catalysts are becoming more limited, which reduces downside risk and supports stable to modest valuation increases.
- Upgrades to Buy ratings indicate renewed confidence in Straumann’s ability to execute as market conditions stabilize.
Bearish Takeaways
- Bearish analysts caution that growth and margin estimates have been reduced due to a shallower than expected recovery in the U.S. market.
- Some have significantly lowered their price targets, reflecting concern over near-term execution and competitive pressures.
- Downgrades and Hold ratings indicate ongoing uncertainty about the pace of recovery, which could cap upside for the shares.
- Limited short-term catalysts and the potential for further downward revisions continue to weigh on some analysts’ outlooks.
What's in the News
- Straumann Holding AG hosted its Analyst/Investor Day and provided updates on company strategy and outlook. (Key Developments)
- Straumann Group and Smartee Denti-Technology announced a strategic partnership focused on co-developing a next-generation orthodontics platform and advancing clear aligner technologies. (Key Developments)
- The Group unveiled new strategic partnerships aimed at transforming its orthodontics business, accelerating innovation for its ClearCorrect brand, and improving efficiency and profitability. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has risen slightly, increasing from CHF 111.61 to CHF 112.43.
- Discount Rate has edged up modestly, moving from 4.57% to 4.60%.
- Revenue Growth projection has declined marginally, from 8.25% to 8.07%.
- Net Profit Margin has improved fractionally, rising from 21.28% to 21.32%.
- Future P/E ratio has increased slightly, from 29.14x to 29.48x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.